Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Meningococcal disease
NITAG documentation
SAGE documentation
Newborn
Clear all
Type of publications
NITAG documentation
(1)
SAGE documentation
(3)
Systematic reviews (SYSVAC)
(25)
Topics
GRADE table
(3)
Recommendation
(1)
Regions
Europe
(1)
Countries
Belgium
(1)
Diseases
COVID-19
(1)
Meningococcal disease
(3)
Hepatitis B
(1)
Influenza
(3)
Malaria
(1)
Pneumococcal disease
(3)
Publication date
2022
(1)
2015
(3)
Target population
Newborn
(4)
Adolescents
(3)
Children
(8)
Pregnant women
(5)
Risk group
(5)
Available to download in languages
English (EN)
(3)
4 results found
2022
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against COVID-19 with mRNA vaccines for children from 6 months of age in Belgium
2015
∙
SAGE
Duration of protection conferred by MenA conjugate vaccination in immunocompetent children (3 to 24 months of age) against serogroup A meningococcal disease
2015
∙
SAGE
Efficacy of a two dose schedule of MenA conjugate vaccination in immunocompetent children (3 to 9 months of age) against serogroup A meningococcal disease
2015
∙
SAGE
Safety of MenA conjugate vaccination in immunocompetent children (3 to 24 months of age)
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register